Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eugenie, Kleinerman"'
Autor:
Long Dao, Dristhi Ragoonanan, Izhar Batth, Arun Satelli, Jessica Foglesong, Jian Wang, Wafik Zaky, Jonathan B. Gill, Diane Liu, Aisha Albert, Nancy Gordon, Winston Huh, Douglas Harrison, Cynthia Herzog, Eugenie Kleinerman, Richard Gorlick, Najat Daw, Shulin Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundDespite advances in care, the 5 year overall survival for patients with relapsed and or metastatic sarcoma remains as low as < 35%. Currently, there are no biomarkers available to assess disease status in patients with sarcomas and as such,
Externí odkaz:
https://doaj.org/article/ecabc7e1fe53496c97da19405d1ff875
Autor:
Savannah V. Wooten, Behrang Amini, J. Andrew Livingston, Michelle A.T. Hildebrandt, Joya Chandra, Susan C. Gilchrist, Michael Roth, Eugenie Kleinerman
Publikováno v:
Journal of Adolescent and Young Adult Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0619864a4dfd272bb01f42391d279309
https://doi.org/10.1089/jayao.2023.0006
https://doi.org/10.1089/jayao.2023.0006
Autor:
Eric Rohren, Homer Macapinlac, Eugenie Kleinerman, Gregory Ravizzini, Funda Meric-Bernstam, David S. Hong, Sant Chawla, Robert S. Benjamin, Joseph A. Ludwig, Neeta Somaiah, Najat C. Daw, Vinod Ravi, Winston W. Huh, Kenneth Hess, Kalevi Kairemo, Pete M. Anderson, Vivek Subbiah
Purpose:The prognosis of metastatic osteosarcoma continues to be poor. We hypothesized that alpha-emitting, bone-targeting radium 223 dichloride (223RaCl2) can be safely administered to patients with osteosarcoma and that early signals of response or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1477909917b008234b5d57157d85bed3
https://doi.org/10.1158/1078-0432.c.6528264.v1
https://doi.org/10.1158/1078-0432.c.6528264.v1
Autor:
Eric Rohren, Homer Macapinlac, Eugenie Kleinerman, Gregory Ravizzini, Funda Meric-Bernstam, David S. Hong, Sant Chawla, Robert S. Benjamin, Joseph A. Ludwig, Neeta Somaiah, Najat C. Daw, Vinod Ravi, Winston W. Huh, Kenneth Hess, Kalevi Kairemo, Pete M. Anderson, Vivek Subbiah
Supplementary file: Previous therapies, Overall survival S1 : Prior therapies of patients with osteosarcoma enrolled on the Radium 223 trial. Supplementary Table S2: Adverse events in patients with osteosarcoma enrolled on the Radium 223 trial. Suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ecdfee1a6ce2c4fe89fc0211b59635
https://doi.org/10.1158/1078-0432.22472565.v1
https://doi.org/10.1158/1078-0432.22472565.v1
Publikováno v:
International Journal of Molecular Sciences. 23:14649
Innate immune cells are the early responders to infection and tissue damage. They play a critical role in the initiation and resolution of inflammation in response to insult as well as tissue repair. Following ischemic or non-ischemic cardiac injury,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::537e8c5c6fd21ce0f8c3b9d9085a6d94
https://doi.org/10.3390/ijms232314649
https://doi.org/10.3390/ijms232314649
Publikováno v:
Circulation Research. 127
Doxorubicin (Dox) is one of the most effective chemotherapy agents for treating childhood cancer. Unfortunately, Dox also causes damage to the heart which leads to reduced heart function and heart failure in >50% of survivors. Understanding the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7d9d1190741d18d09ea9d4618ceb153
https://doi.org/10.1161/res.127.suppl_1.269
https://doi.org/10.1161/res.127.suppl_1.269
Autor:
Izhar S. Batth, Wafik Zaky, Soumen Khatua, Najat C. Daw, Kris M. Mahadeo, Sajad Khazal, Aisha Albert, Wilber Huang, Diva Chen, Jonathan B. Gill, Eugenie Kleinerman, Richard Gorlick, Shulin Li
Publikováno v:
Cancer Research. 79:1345-1345
The clinical utility of blood analysis such as circulating tumor cells (CTCs) has garnered increasing interest in recent years. However very few studies were conducted in pediatric cancer patients especially in brain tumor, osteosarcoma, and leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c836d8cc0afe1f448c8e7e4695cb90f
https://doi.org/10.1158/1538-7445.am2019-1345
https://doi.org/10.1158/1538-7445.am2019-1345
Autor:
Sarina A, Piha-Paul, Sang Joon, Shin, Tribhawan, Vats, Nandita, Guha-Thakurta, Joann, Aaron, Michael, Rytting, Eugenie, Kleinerman, Razelle, Kurzrock
Publikováno v:
Anticancer research. 34(4)
Pre-clinical findings suggest that combination treatment with bevacizumab and temsirolimus could be effective against malignant pediatric central nervous system (CNS) tumors.Six pediatric patients were treated as part of a phase I trial with intraven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de2a778f40454bd1aa6ae320e1ef6cb9
https://pubmed.ncbi.nlm.nih.gov/24692729
https://pubmed.ncbi.nlm.nih.gov/24692729
Autor:
Yong Xin, Wang, Deendayal, Mandal, Suizhau, Wang, Dennis, Hughes, Raphael E, Pollock, Dina, Lev, Eugenie, Kleinerman, Andrea, Hayes-Jordan
Publikováno v:
In vivo (Athens, Greece). 23(6)
Despite aggressive therapy, Ewing's sarcoma (ES) patients have a poor five-year overall survival of only 20-40%. Pulmonary metastasis is the most common form of demise in these patients. The pathogenesis of pulmonary metastasis is poorly understood a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f329c7998d952414a71b5bc85f78ed2c
https://pubmed.ncbi.nlm.nih.gov/20023231
https://pubmed.ncbi.nlm.nih.gov/20023231
Autor:
Carlos O. Rodriguez, Torrie A. Crabbs, Dennis W. Wilson, Virginia A. Cannan, Katherine A. Skorupski, Nancy Gordon, Nadya Koshkina, Eugenie Kleinerman, Peter M. Anderson
Publikováno v:
Journal of Aerosol Medicine & Pulmonary Drug Delivery; Aug2010, Vol. 23 Issue 4, p197-206, 10p